Safety, Tolerability, and Efficacy of IONIS-GHR-LRx in up to 42 Adult Patients With Acromegaly Being Treated With Long-acting Somatostatin Receptor Ligands

Condition:   Acromegaly Interventions:   Drug: IONIS-GHR-LRx;   Drug: Placebo Sponsor:   Ionis Pharmaceuticals, Inc. Not yet recruiting

Source: ClinicalTrials.gov - June 7, 2018 Category: Research Source Type: clinical trials